| pubmed-article:11711842 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11711842 | lifeskim:mentions | umls-concept:C0007452 | lld:lifeskim |
| pubmed-article:11711842 | lifeskim:mentions | umls-concept:C0035330 | lld:lifeskim |
| pubmed-article:11711842 | lifeskim:mentions | umls-concept:C0005320 | lld:lifeskim |
| pubmed-article:11711842 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11711842 | lifeskim:mentions | umls-concept:C0022203 | lld:lifeskim |
| pubmed-article:11711842 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11711842 | pubmed:dateCreated | 2001-11-16 | lld:pubmed |
| pubmed-article:11711842 | pubmed:abstractText | RS-Betaxolol (equimolar R- and S- isomers) lowers intraocular pressure and dilates precontracted retinal and posterior ciliary arteries in vitro. Betaxolol's vasorelaxant effect is thought to involve the inhibition of calcium influx into vascular smooth muscle and is unrelated to its stereoselective beta-adrenergic blocking action. The authors assessed the vasodilatory effect of RS-betaxolol on different diameters of bovine retinal arterioles and venules, and these responses were compared with the responses induced by R- and S-betaxolol isomers in vitro. | lld:pubmed |
| pubmed-article:11711842 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11711842 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11711842 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11711842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11711842 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11711842 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11711842 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11711842 | pubmed:issn | 1057-0829 | lld:pubmed |
| pubmed-article:11711842 | pubmed:author | pubmed-author:DeSantisLL | lld:pubmed |
| pubmed-article:11711842 | pubmed:author | pubmed-author:KulkarniP SPS | lld:pubmed |
| pubmed-article:11711842 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11711842 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:11711842 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11711842 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11711842 | pubmed:pagination | 423-6 | lld:pubmed |
| pubmed-article:11711842 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:meshHeading | pubmed-meshheading:11711842... | lld:pubmed |
| pubmed-article:11711842 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11711842 | pubmed:articleTitle | Vasorelaxant effects of racemic betaxolol and its R- and S- isomers on bovine retinal vessels. | lld:pubmed |
| pubmed-article:11711842 | pubmed:affiliation | Department of Ophthalmology and Visual Science, School of Medicine at University of Louisville, Louisville, Kentucky 40202, USA. | lld:pubmed |
| pubmed-article:11711842 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11711842 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11711842 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11711842 | lld:pubmed |
